Literature DB >> 22383742

The role of antifungal treatment in hematology.

Johan A Maertens, Marcio Nucci, J Peter Donnelly.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22383742      PMCID： PMC3291583          DOI： 10.3324/haematol.2012.061952

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Authors:  Oliver A Cornely; Johan Maertens; Drew J Winston; John Perfect; Andrew J Ullmann; Thomas J Walsh; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow-Tee Goh; Mario Petrini; Cathy Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

2.  Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

Authors:  Johan Maertens; Koen Theunissen; Gregor Verhoef; Johnny Verschakelen; Katrien Lagrou; Eric Verbeken; Alexander Wilmer; Jan Verhaegen; Marc Boogaerts; Johan Van Eldere
Journal:  Clin Infect Dis       Date:  2005-09-29       Impact factor: 9.079

Review 3.  Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?

Authors:  Thomas R Rogers; Monica A Slavin; J Peter Donnelly
Journal:  Br J Haematol       Date:  2011-04-20       Impact factor: 6.998

Review 4.  Optimizing management of invasive mould diseases.

Authors:  Samir Agrawal; William Hope; János Sinkó; Christopher Kibbler
Journal:  J Antimicrob Chemother       Date:  2011-01       Impact factor: 5.790

5.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

Authors:  J L Goodman; D J Winston; R A Greenfield; P H Chandrasekar; B Fox; H Kaizer; R K Shadduck; T C Shea; P Stiff; D J Friedman
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

Review 6.  Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis.

Authors:  Elad Goldberg; Anat Gafter-Gvili; Eyal Robenshtok; Leonard Leibovici; Mical Paul
Journal:  Eur J Cancer       Date:  2008-08-14       Impact factor: 9.162

7.  Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.

Authors:  R A Barnes; P L White; C Bygrave; N Evans; B Healy; J Kell
Journal:  J Clin Pathol       Date:  2009-01       Impact factor: 3.411

8.  An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.

Authors:  F L Dignan; S O Evans; M E Ethell; B E Shaw; F E Davies; C E Dearden; J G Treleaven; U B G Riley; G J Morgan; M N Potter
Journal:  Bone Marrow Transplant       Date:  2009-01-12       Impact factor: 5.483

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 10.  Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint.

Authors:  Johan Maertens; Kristel Buvé; Elias Anaissie
Journal:  J Natl Compr Canc Netw       Date:  2008-02       Impact factor: 11.908
View more
  21 in total

1.  Pathogen identification by nuclear imaging--almost there?

Authors:  Samir G Agrawal; Stephen J Mather
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07       Impact factor: 9.236

2.  Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.

Authors:  Almudena Martín-Peña; M Victoria Gil-Navarro; Manuela Aguilar-Guisado; Ildefonso Espigado; Maite Ruiz Pérez de Pipaón; José Falantes; Jerónimo Pachón; José M Cisneros
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

3.  The diagnostic role of galactomannan during antifungal prophylaxis. Comment on: "The role of antifungal treatment in hematology". Haematologica 2012;97(3):325-7.

Authors:  Corrado Girmenia; Salvatore Perrone
Journal:  Haematologica       Date:  2012-10       Impact factor: 9.941

4.  The management of febrile neutropenia in the posaconazole era: a new challenge?

Authors:  Livio Pagano; Morena Caira; Manuel Cuenca-Estrella
Journal:  Haematologica       Date:  2012-07       Impact factor: 9.941

5.  Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.

Authors:  Gemma L Johnson; Shah-Jalal Sarker; Francesco Nannini; Arianna Ferrini; Emma Taylor; Cornelia Lass-Flörl; Wolfgang Mutschlechner; Stephen A Bustin; Samir G Agrawal
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

6.  Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational study.

Authors:  Xiaochen Chen; Jianxiang Wang; Sanbin Wang; Jie Jin; Junmin Li; Sujun Gao; Jianyong Li; Juan Li; Qifa Liu; Yu Hu; Dongjun Lin; Zimin Sun; Jianmin Yang; Jianda Hu; Xiaoxiong Wu; Xiaojun Huang; Zonghong Shao; Qi Deng; Chun Wang; Li Liu; Hu Chen; Jingbo Wang; Xudong Wei; Jianping Shen; Xi Zhang; Depei Wu
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

7.  Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.

Authors:  Junru Liu; He Huang; Yan Li; Lin Liu; Jianyong Li; Zhuogang Liu; Jin Lu; Jian Ouyang; Yongping Song; Daobin Zhou; Hanyun Ren; Jun Ma; Chun Wang; Li Yu; Jin Zhou; Jianmin Wang; Yang Xiao; Xiaojun Huang; Juan Li
Journal:  Tumour Biol       Date:  2015-12-23

8.  Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patients.

Authors:  S Harricharan; K Biederman; A M Bombassaro; A Lazo-Langner; S Elsayed; A Fulford; J A Delport; A Xenocostas
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

9.  Impact of antifungal stewardship interventions on the susceptibility of colonized Candida species in pediatric patients with malignancy.

Authors:  Ali Amanati; Parisa Badiee; Hadis Jafarian; Fatemeh Ghasemi; Samane Nematolahi; Sezaneh Haghpanah; Seyedeh Sedigheh Hamzavi
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

10.  Use of antifungal drugs in hematology.

Authors:  Marcio Nucci
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.